Stress Test Results and Evidence Strength
Critically evaluate the sample sizes, statistical significance, and potential biases within the experiment findings. Assess whether the data gathered is sufficiently robust to support major commercial and resource allocation decisions.
Rigorous quality review prevents the venture from acting on false positives, flawed sample sizes, or confirmation bias. It ensures that strategic pivots or capital deployments are backed by high-conviction, repeatable evidence.
A written evidence audit highlighting sample size validity, confidence intervals, and identified testing anomalies. The assessment must classify evidence strength as high, medium, or low, explicitly citing potential confounding factors.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
How did you ensure your sample size was statistically significant before drawing strategic conclusions?
- 2
What external variables or platform anomalies might have skewed your campaign results?
- 3
Why should investors trust this evidence given the limited run time or small budget of the tests?
- 4
How did you guard against confirmation bias when interpreting ambiguous customer engagement metrics?
- 5
Which findings require further validation before you commit substantial capital to scaling the channel?
